Embarrassing’ Blackouts Mar Affordability Plan to Help Californians with Multimillion-Dollar Gene Therapy
Summary
CIRM and Rocket should be applauded for putting together an assistance plan, said Hank Greely, a Stanford University law professor and director of its Center for Law and the Biosciences, in an interview this week. He also said some of the redactions are “embarrassing” and “uninformative.”
“It is in CIRM’s interest, as well as in the public interest, that the public knows what’s going on….What’s proprietary about the documentation needed to establish the right residency?” Greely said.
Read More